Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
NuCycle Appoints New CEO
October 1, 2000
1 Min Read
NuCycle Appoints New CEO
MONMOUTH JUNCTION, N.J.--NuCycle Therapy Inc. appointed John Benemann, Ph.D., as president and chief executive officer, taking over for Burt Ensley, who will continue to work with NuCycle in technology development and intellectual property matters. Prior to starting his position at NuCycle on Aug. 1, Benemann worked as an independent consultant at the University of California.
In related news, NuCycle has just received a patent for its line of nutritional supplements. The line includes PhytoSel, PhytoChrom, MultiMins, PhytoZinc and PhytoIron. The latter two products will be available in the next three to five months, according to Benemann. For more information, call (925) 939-5864 or visit Booth #1929 at SupplySide West.
You May Also Like
